Dr. Helget is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Nebraska Medicine Specialty Medicine Clinic at Durham Outpatient Center
4400 Emile St
Omaha, NE 68198Phone+1 402-391-3800
Education & Training
- Medical University of South CarolinaResidency, Internal Medicine, 2016 - 2019
- University of Nebraska College of MedicineClass of 2016
Certifications & Licensure
- NE State Medical License 2021 - 2026
- SC State Medical License 2016 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- Reply.Lindsay N Helget, Ted R Mikuls
Arthritis & Rheumatology. 2024-11-01 - 1 citationsEfficacy and Safety of Allopurinol and Febuxostat in Patients With Gout and CKD: Subgroup Analysis of the STOP Gout Trial.Lindsay N Helget, Anne Davis-Karim, James R O'Dell, Ted R Mikuls, Jeff A Newcomb
American Journal of Kidney Diseases. 2024-11-01 - 1 citationsComparison of Gout Flares With the Initiation of Treat-to-Target Allopurinol and Febuxostat: A Post-Hoc Analysis of a Randomized Multicenter Trial.Austin Barry, Lindsay N Helget, Maria Androsenko, Hongsheng Wu, Bridget Kramer
Arthritis & Rheumatology. 2024-10-01
Press Mentions
- Allopurinol, Febuxostat Have Similar Efficacy in Stage 3 CKD with GoutAugust 15th, 2024
- Gout Prevalence Is Increasing Among US VeteransSeptember 22nd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: